A detailed history of Squarepoint Ops LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Squarepoint Ops LLC holds 20,121 shares of CNTA stock, worth $345,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,121
Holding current value
$345,276
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.58 - $16.99 $172,638 - $341,855
20,121 New
20,121 $321,000
Q3 2021

Nov 15, 2021

SELL
$16.7 - $23.11 $630,775 - $872,887
-37,771 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$21.71 - $25.66 $820,008 - $969,203
37,771 New
37,771 $839,000

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.62B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.